5.13 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.901
EU - Europa 7.462
AS - Asia 5.278
SA - Sud America 555
Continente sconosciuto - Info sul continente non disponibili 397
AF - Africa 102
OC - Oceania 2
Totale 24.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.734
IT - Italia 2.430
CN - Cina 1.450
RU - Federazione Russa 1.318
SG - Singapore 1.218
SE - Svezia 1.118
IE - Irlanda 755
KR - Corea 680
TR - Turchia 538
DE - Germania 475
BR - Brasile 417
UA - Ucraina 385
VN - Vietnam 376
GB - Regno Unito 310
HK - Hong Kong 303
BD - Bangladesh 297
FR - Francia 182
FI - Finlandia 159
IN - India 128
CH - Svizzera 117
CA - Canada 80
AT - Austria 60
IQ - Iraq 46
PK - Pakistan 37
MX - Messico 36
AR - Argentina 35
NL - Olanda 34
SA - Arabia Saudita 31
ZA - Sudafrica 31
ID - Indonesia 27
CO - Colombia 26
VE - Venezuela 26
AL - Albania 23
UZ - Uzbekistan 22
ES - Italia 21
EU - Europa 21
PL - Polonia 21
AE - Emirati Arabi Uniti 20
MY - Malesia 20
BE - Belgio 19
EC - Ecuador 18
JP - Giappone 18
TN - Tunisia 15
MA - Marocco 14
PH - Filippine 13
LT - Lituania 10
CL - Cile 9
EG - Egitto 9
PE - Perù 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
JM - Giamaica 5
NI - Nicaragua 5
NP - Nepal 5
UY - Uruguay 5
HN - Honduras 4
BG - Bulgaria 3
BO - Bolivia 3
KG - Kirghizistan 3
PR - Porto Rico 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 24.299
Salva come PNG Salva come JPEG
Città #
Council Bluffs 1.561
Pisa 996
Ashburn 974
San Jose 922
Jacksonville 857
Dublin 751
Chandler 747
Dallas 729
Seoul 674
Singapore 473
Boardman 461
Izmir 396
Wilmington 364
Ann Arbor 325
Moscow 313
Beijing 310
Hong Kong 286
Milan 269
Hefei 249
Düsseldorf 182
Boston 179
Millbury 175
New York 148
Dong Ket 144
Los Angeles 137
Clifton 129
Kent 115
San Mateo 115
Rome 112
Istanbul 109
Lauterbourg 105
Mestre 104
The Dalles 99
Bern 92
Seattle 88
Woodbridge 86
Chicago 84
Dearborn 78
Ho Chi Minh City 77
Bremen 76
Santa Clara 72
Lawrence 71
North Bergen 66
Ogden 65
Florence 63
Scuola 60
Brescia 59
Buffalo 59
Hanoi 56
Norwalk 56
Phoenix 56
Princeton 54
Vienna 54
Guangzhou 43
Saint Petersburg 43
San Giuliano Terme 41
Munich 38
São Paulo 36
Helsinki 32
Orem 32
Shanghai 31
Spartanburg 31
Toronto 29
Chennai 28
Miano 26
Parkland 26
London 25
Brooklyn 24
Figino 24
Naples 24
San Antonio 24
Montreal 23
Wuhan 22
Nanjing 21
Padova 21
Turin 20
Washington 20
Atlanta 19
Manchester 19
Tashkent 19
Warsaw 19
Denver 18
Houston 18
Johannesburg 18
Kunming 18
Zurich 18
Baghdad 16
Brussels 16
Needham 15
Tokyo 15
Andover 14
Frankfurt am Main 14
Jiaxing 14
Keene 14
Da Nang 13
Jinan 13
Mexico City 13
Rio de Janeiro 13
Turku 13
Ankara 12
Totale 15.927
Salva come PNG Salva come JPEG
Nome #
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 336
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 330
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 325
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 323
Bucket brigade address decoding architecture for classical and quantum random access memories 303
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 303
Composti particolarmente catalizzatori di poliuretani 295
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 294
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 286
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 284
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 282
Method and device for measuring position and mass 275
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 270
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 262
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 261
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 254
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 253
Laser circolari a semiconduttore con reticoli per emissione verticale 241
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 231
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 219
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 215
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 208
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 203
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 202
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 199
Method for the humanization of antibodies and humanized antibodies thereby obtained 199
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 199
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 198
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 195
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 192
INTRACELLULAR ANTIBODIES 191
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 189
Method for the humanization of antibodies and humanized antibodies thereby obtained 188
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 186
Method for the humanization of antibodies and humanized antibodies thereby obtained. 186
Device and method for processing a digital video 185
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 185
Method for the potentiation of opioid analgesics effects on pain 184
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 184
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 184
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 184
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 176
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 176
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 175
Novel analgesic treatment with prolonged effect 175
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 175
Intracellular selection 175
Method of identifying a consensus sequence for intracellular antibodies 175
Method for the humanization of antibodies and humanized antibodies thereby obtained. 174
Selection of intracellular immunoglobulins 174
Intracellular selection 172
Method for the potentiation of opioid analgesics effects on pain 172
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 172
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 171
Intracellular selection 171
Selection of intracellular immunoglobulins 171
Selection of intracellular immunoglobulins 171
Novel analgesic treatment with prolonged effect 171
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 171
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 170
Humanized anti-NGF antibodies 170
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 169
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 169
Humanized anti-NGF antibodies 168
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 167
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 167
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 167
Method for the humanization of antibodies and humanized antibodies thereby obtained 167
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 166
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 166
INTRACELLULAR ANTIBODIES 166
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 166
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 165
Method for the humanization of antibodies and humanized antibodies thereby obtained. 165
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 165
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 165
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 165
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 164
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 163
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 163
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 163
Method for the humanization of antibodies and humanized antibodies thereby obtained. 163
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 162
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 161
Selection of intracellular immunoglobulins 161
Non-human transgenic animals for the study of neurodegenerative syndromes 160
Humanized anti-NGF antibodies 159
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 158
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 158
Humanized anti-NGF antibodies 158
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 158
Novel analgesic treatment with prolonged effect 157
Selection of intracellular immunoglobulins 157
Method for the humanization of antibodies and humanized antibodies thereby obtained 156
Method for the potentiation of opioid analgesics effects on pain 155
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 155
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 155
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 155
Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis Thereof 153
Method for the humanization of antibodies and humanized antibodies thereby obtained. 153
Totale 19.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022772 0 0 0 121 15 5 10 69 50 58 19 425
2022/20233.491 239 136 136 218 159 378 0 970 1.112 22 38 83
2023/20241.158 208 48 93 31 53 120 18 116 195 22 18 236
2024/20253.201 92 34 174 168 468 14 39 187 643 147 594 641
2025/20267.805 541 653 971 683 298 315 1.090 456 963 582 564 689
2026/20273.387 1.249 336 509 1.293 0 0 0 0 0 0 0 0
Totale 24.697